Feasibility of Recombinant Human TSH as a Preparation for Radioiodine Therapy in Patients with Distant Metastases from Papillary Thyroid Cancer: Comparison of Long-Term Survival Outcomes with Thyroid Hormone Withdrawal.
Hsi-Chen TsaiKung-Chu HoShih-Hsin ChenJing-Ren TsengLan-Yan YangKun-Ju LinJu-Chin ChengMiaw-Jene LiouPublished in: Diagnostics (Basel, Switzerland) (2022)
Preparation for RAI therapy using rhTSH stimulation is not inferior to THW preparation in terms of long-term survival outcomes experienced by patients with PTC and distant metastasis. Patients with RAI-avid metastases and preparation with rhTSH had the most favorable PFS.